The release of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha plays a critical role in this process, as these cytokines can exacerbate endothelial dysfunction and promote further inflammatory responses (Fornasiero et al., 2022). The gene discussed is IL6; the disease is endothelial dysfunction.